Company News
Dr. Reddy's Launches First-to-Market Bosutinib in US
• Dr. Reddy's announces first-to-market US launch of generic Bosutinib 400mg Tablets, a cancer drug, on June 13, 2026.
• The product, developed and manufactured by MSN Laboratories, is eligible for 18
